Análisis crítico de ensayos clínicos. ¿Es oro todo lo que reluce?

Coumou, 2006, How do primary care physicians seek answers to clinical questions? A literature review, J Med Libr Assoc, 94, 55 Jadad, 1998 Scott, 2005, Cautionary tales in the clinical interpretation of therapeutic trial reports, Intern Med J, 35, 611, 10.1111/j.1445-5994.2005.00929.x Using evidence to guide practice. MeReC Briefing. 2005; 30:1-8. Peiró, 2005, La construcción de la evidence based medicine, Gestión Clínica y Sanitaria, 7, 131 Melander, 2003, Evidence based medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications, BMJ, 326, 1171, 10.1136/bmj.326.7400.1171 Smith, 2005, Medical journals are an extension of the marketing arm of pharmaceutical companies, PLoS Med, 2, e138., 10.1371/journal.pmed.0020138 Lexchin, 2003, Pharmaceutical industry sponsorship and research outcome and quality: systematic review, BMJ, 326, 1167, 10.1136/bmj.326.7400.1167 ls-Nielsen, 2003, Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?, JAMA, 290, 921, 10.1001/jama.290.7.921 Evaluating clinical evidence-what do I need to know? WeMeReC Bulletin. 2006;May:1-6. Oxman, 1993, Users’ guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group, JAMA, 270, 2093, 10.1001/jama.270.17.2093 Evans, 2001, Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice?, Arch Intern Med, 161, 1443, 10.1001/archinte.161.11.1443 Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators, N Engl J Med, 341, 709, 10.1056/NEJM199909023411001 Juurlink, 2004, Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study, N Engl J Med, 351, 543, 10.1056/NEJMoa040135 Psaty, 2006, Recent trials in hypertension: compelling science or commercial speech?, JAMA, 295, 1704, 10.1001/jama.295.14.1704 Dahlof, 2005, Lancet, 366, 895, 10.1016/S0140-6736(05)67185-1 Espeland, 1998, Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions, Circulation, 97, 979, 10.1161/01.CIR.97.10.979 Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From theWomen’s Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321 Pitt, 1997, Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE), Lancet, 349, 747, 10.1016/S0140-6736(97)01187-2 Pitt, 2000, Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II, Lancet, 355, 1582, 10.1016/S0140-6736(00)02213-3 Montori, 2005, Validity of composite end points in clinical trials, BMJ, 330, 594, 10.1136/bmj.330.7491.594 Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial. Lancet. 2001; 358(9286):951-7. Ioannidis, 2004, Better reporting of harms in randomized trials: an extension of the CONSORT statement, Ann Intern Med, 141, 781, 10.7326/0003-4819-141-10-200411160-00009 Connolly, 2000, Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone, Circulation, 101, 1297, 10.1161/01.CIR.101.11.1297 Bokhari, 2004, Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS), Circulation, 110, 112, 10.1161/01.CIR.0000134957.51747.6E Schulz, 1995, Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials, JAMA, 273, 408, 10.1001/jama.1995.03520290060030 Moher, 2001, The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials, JAMA, 285, 1987, 10.1001/jama.285.15.1987 Hansson, 1999, Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial, Lancet, 353, 611, 10.1016/S0140-6736(98)05012-0 Fergusson, 2002, Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis, BMJ, 325, 652, 10.1136/bmj.325.7365.652 Piaggio, 2006, JAMA, 295, 1152, 10.1001/jama.295.10.1152 Fox, 2004, Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial, Circulation, 110, 1202, 10.1161/01.CIR.0000140675.85342.1B Bucher, 1994, Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration, BMJ, 309, 761, 10.1136/bmj.309.6957.761 Hux, 1995, Communicating the benefits of chronic preventive therapy: does the format of efficacy data determine patients’ acceptance of treatment?, Med Decis Making, 15, 152, 10.1177/0272989X9501500208 Schulz, 2005, Multiplicity in randomised trials II: subgroup and interim analyses, Lancet, 365, 1657, 10.1016/S0140-6736(05)66516-6 Freemantle, 2001, Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?, BMJ, 322, 989, 10.1136/bmj.322.7292.989 Montori, 2004, Users’ guide to detecting misleading claims in clinical research reports, BMJ, 329, 1093, 10.1136/bmj.329.7474.1093 Critical Appraisal Skills Programme (CASP) and evidence-based practice. Disponible en: http://www phru nhs uk/casp/casp htm [Acceso enero 2007. Caspe. Programa de habilidades en lectura crítica España. Disponible en: http://www redcaspe org/homecasp.asp [Acceso enero 2007].